000			03297nam a22004815i 4500
001			978-3-642-29866-0
003			DE-He213
005			20140220083317.0
007			cr nn 008mamaa
008			121026s2012 gw | s |||| 0|eng d
020			_a9783642298660 _9978-3-642-29866-0
024	7		_a10.1007/978-3-642-29866-0 _2doi
050		4	_aR895-920
072		7	_aMMPH _2bicssc
072		7	_aMMP _2bicssc
072		7	_aMED008000 _2bisacsh
082	0	4	_a616.0757 _223
100	1		_aMihailovic, Jasna. _eauthor.
245	1	0	_aFDG PET/CT in Clinical Oncology _h[electronic resource] : _bCase Based Approach with Teaching Points / _cby Jasna Mihailovic, Stanley J. Goldsmith, Ronan P. Killeen.
264		1	_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg : _bImprint: Springer, _c2012.
300			_aXIV, 453 p. 113 illus., 108 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aPART ONE – DIAGNOSIS: Solitary pulmonary nodule/chest mass -- Unknown primary -- Unsuspected malignancy/second primary -- PART TWO – EXTENT OF DISEASE: Head & Neck -- Lung -- Breast -- Esophageal -- Colorectal -- Lymphoma -- Multiple Myeloma -- Gynecology -- Miscellaneous -- PART THREE – FOLLOW UP: Lung Ca -- Breast  Ca -- Pancreas Ca -- Colorectal Ca -- Lymphoma -- Multiple Myeloma -- Thyroid Gland -- Urologic -- Miscellaneous -- PART FOUR - EVALUATION OF RESPONSE: Lymphoma -- Multiple Mueloma -- Lung -- Gastrointestinal Tumors -- Breast -- Neuroendocrine Tumor.
520			_aFDG PET/CT has rapidly emerged as an invaluable combined imaging modality that can identify tumors on the basis of not only anatomical alterations but also metabolic activity, thus allowing the detection of lesions that would otherwise be too small to distinguish. This book, comprising a collection of images from oncology cases, is organized according to the role of FDG PET/CT in the evaluation and management of oncology patients, and only secondarily by organ or tumor entity. In this way, it reflects the issues that clinicians actually address in their daily practice, namely: identification of an unknown or unsuspected primary; determination of the extent of disease; evaluation of response to therapy; and surveillance after response, i.e., detection of recurrent disease. In total, 100 cases involving different primary tumors are presented to illustrate findings in these different circumstances. FDG PET/CT in Clinical Oncology will be of great value to all newcomers to this field, whether medical students, radiology, nuclear medicine, or oncology fellows, or practicing physicians.
650		0	_aMedicine.
650		0	_aRadiology, Medical.
650		0	_aOncology.
650	1	4	_aMedicine & Public Health.
650	2	4	_aImaging / Radiology.
650	2	4	_aOncology.
650	2	4	_aDiagnostic Radiology.
700	1		_aGoldsmith, Stanley J. _eauthor.
700	1		_aKilleen, Ronan P. _eauthor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783642298653
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-642-29866-0
912			_aZDB-2-SME
999			_c103100 _d103100